242 related articles for article (PubMed ID: 27296931)
21. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
Larkin SJ; Ferraù F; Karavitaki N; Hernández-Ramírez LC; Ansorge O; Grossman AB; Korbonits M
Eur J Endocrinol; 2014 Dec; 171(6):705-10. PubMed ID: 25225481
[TBL] [Abstract][Full Text] [Related]
23. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical Adenomas.
Seidel E; Scholl UI
Front Endocrinol (Lausanne); 2016; 7():75. PubMed ID: 27445978
[TBL] [Abstract][Full Text] [Related]
25. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
26. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase A defects and cortisol-producing adrenal tumors.
Zilbermint M; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
[TBL] [Abstract][Full Text] [Related]
30. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
[TBL] [Abstract][Full Text] [Related]
31. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
32. PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations.
Dalmazi GD; Beuschlein F
Horm Metab Res; 2017 Apr; 49(4):301-306. PubMed ID: 27871112
[TBL] [Abstract][Full Text] [Related]
33. ACTH-independent Cushing's syndrome due to ectopic endocrinologically functional adrenal tissue caused by a
Takedani K; Yamamoto M; Tanaka S; Ishihara S; Taketani T; Kanasaki K
Front Endocrinol (Lausanne); 2022; 13():934748. PubMed ID: 35966069
[TBL] [Abstract][Full Text] [Related]
34. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.
Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ
Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369
[TBL] [Abstract][Full Text] [Related]
35. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
[TBL] [Abstract][Full Text] [Related]
36. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM; Regazzo D; Rubin B; Ferrara AM; Rizzati S; Taschin E; Ceccato F; Arnaldi G; Pecori Giraldi F; Stigliano A; Cerquetti L; Grimaldi F; De Menis E; Boscaro M; Iacobone M; Occhi G; Scaroni C
Endocrine; 2017 Mar; 55(3):959-968. PubMed ID: 27094308
[TBL] [Abstract][Full Text] [Related]
37. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
38. Frequent protein kinase A regulatory subunit A1 mutations but no GNAS mutations as potential driver in sporadic cardiac myxomas.
Zimpfer A; Abel LM; Alozie A; Etz CD; Schneider B
Cardiovasc Pathol; 2024; 71():107632. PubMed ID: 38492686
[TBL] [Abstract][Full Text] [Related]
39. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
[TBL] [Abstract][Full Text] [Related]
40. The mystery of transient pregnancy-induced cushing's syndrome: a case report and literature review highlighting GNAS somatic mutations and LHCGR overexpression.
Li Y; Lin J; Fu S; Li L; Huang Z; Yang H; Liang X; Qin Y; Zhou J; Liu D; Luo Z
Endocrine; 2024 Feb; 83(2):473-482. PubMed ID: 37828397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
